Bayer - Cardiac MR for CAD Using a Standard Dose of Gadavist-Bayer - Cardiac MR for CAD Using a Standard Dose of Gadavist

Video Transcription

Video Summary

The presentation explains how gadolinium-based contrast agent GATAVIST is used in cardiac MRI to evaluate known or suspected coronary artery disease. It reviews stress and rest myocardial perfusion imaging and late gadolinium enhancement (LGE), emphasizing that MRI can detect functionally significant stenosis, myocardial scar, ischemia, and viability better than purely anatomical imaging alone.<br /><br />The speaker summarizes two phase 3 trials showing high sensitivity and specificity for detecting coronary disease using a single standard dose of GATAVIST split into stress and rest injections. Safety information is also reviewed, including risks of hypersensitivity, nephrogenic systemic fibrosis in patients with severe kidney dysfunction, and gadolinium retention concerns.<br /><br />Several case examples illustrate clinical use. MRI identified reversible perfusion defects that matched significant coronary lesions on angiography, leading to treatments such as stenting or bypass surgery. In one case, MRI helped clarify disease despite normal resting function and no scar. In another, diffuse multivessel ischemia was detected and later confirmed invasively. The talk concludes that GATAVIST-enhanced cardiac MRI is a valuable, approved tool for coronary disease assessment.

Keywords

GATAVIST

cardiac MRI

coronary artery disease

myocardial perfusion imaging

late gadolinium enhancement

ischemia

gadolinium-based contrast agent